Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › CA › Costa Mesa › NPI 1134894512
Lab

Community Diagnostics LLC

Community Diagnostics LLC was paid $272K by Medicaid between Aug 2021 and Jul 2023, across 4 billing codes. Its largest line is U0004, 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r — 73% of everything it billed.

33Billing provider infoCOMMUNITY DIAGNOSTICS LLC
COSTA MESA, CA 92626
33aNPI1134894512assigned 08/09/2021
28Total paid$272K
24GClaims7,676
24DCodes billed4
24AFirst – last monthAug 2021 – Jul 2023
Compared with peers

Next to other Clinical Medical Laboratory providers in California

Rank by total paid#269 of 561
Median peer was paid$222K
This provider vs. median1.2×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$10K$20K$30K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20211,321$48K
20225,447$215K
2023908$8K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r 73% 3,116 1,038 $199K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 13% 2,109 718 $34K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 11% 1,543 531 $31K
K1034 Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count 2.9% 908 902 $8K

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialKAUFMAN, ZACHARY (PRESIDENT)